PrePOURTSNCT06262048
Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial
StatusUnknown
PhasePhase 2
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Primary completion date: Dec 30, 2024 to Dec 30, 2025
- Start date changed from estimate of Jul 1, 2024 to Oct 1, 2024
- Study completion date: May 31, 2025 to Feb 1, 2026
- Site details revised
Notable Start date: Apr 1, 2024 to Jul 1, 2024v2 Show 5 more changesShow less
- Eligibility criteria expanded, about 83 words
- Primary endpoints: 1 to 3
- Enrollment target: 64 to 60
- Primary completion date: Apr 30, 2025 to Dec 30, 2024
- Study description shortened, about 24 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Enrollment Effectiveness
Timeframe: 4 months
Monthly recruitment
Timeframe: 4 months
Protocol adherence
Timeframe: 4 Months
Secondary (6)
Rate of Straight Catheterizations
Rate of Indwelling Catheterizations
Time to first catheterization
Treatment Related Adverse Events
Catheter related complications
Show 1 moreShow less
Length of stay
Arms and interventions
TreatmentExperimental
Tamsulosin
PlaceboPlacebo comparator
Placebo
Drugs: Tamsulosin Hydrochloride
Other: Placebo
Sites
1 site in 1 country
- London Health Sciences CentreLondon, Ontario, Canada